3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Breast Neoplasms
8
Prostatic Neoplasms
5
Polycystic Ovary Syndrome
5
Multiple Myeloma
5
Colorectal Neoplasms
5
Small Cell Lung Carcinoma
4
Rectal Neoplasms
3
Neoplasms
3
Neoplasm Metastasis
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Fibrosis
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma, Hepatocellular
2
Breast Carcinoma In Situ
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Venous Thromboembolism
1
Urinary Bladder Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Thrombosis
1
Sprains and Strains
1
Smoldering Multiple Myeloma
1
Sepsis
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Interventions
Carboplatin
26
Etoposide
22
Vincristine
18
Melphalan
14
Filgrastim
14
Topotecan
11
Granulocyte Colony-Stimulating Factor
10
Cyclophosphamide
9
Thiotepa
7
Cryotherapy
6
Peripheral Blood Stem Cell Transplantation
4
Mesna
4
Drug Therapy
4
Busulfan
4
Radiotherapy
3
Ifosfamide
3
Doxorubicin
3
Temozolomide
2
Platinum Compounds
2
Eye Enucleation
2
Cisplatin
2
Brachytherapy
2
trioctyl phosphine oxide
1
sargramostim
1
racotumomab
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
etoposide phosphate
1
cixutumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Retinoblastoma
×
Simvastatin
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled